GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.

OTCPK:GBGPF - Post by User

GB Group Ord Shs > Fact: Aurora has 170M shares & $200M CMED's attention

<< Previous

Bullboard Posts

Next >>

Comment by Supermariogon Jan 20, 2018 11:21am

119 Views

Post# 27400621

RE:Fact: Aurora has 170M shares & $200M CMED's attention

You are really of bad faith (maybe bad translation) but you put lots of work to try to explain it. Read this ... 38% of voting shares held by 3 investing companies asked for that. Which percent of shares does BZ have ? Less than 10% approx. Something that you don't understand here ? But it looks like you will die to explain it to everybody who will not have any influence on the outcome. See you on monday and try to expand your understanding of the take over actions. If you ahve much dough in the market, it's dangerous the way you think. :-(

The price being offered by Aurora for each CanniMed Share, which would currently be equivalent to the Cap Price (as such term is defined below) of $24.00 payable in Aurora Shares given Aurora's closing share price of $6.42 on November 22, 2017, represents a compelling premium of 56.9% over the closing price of CanniMed Shares on November 14, 2017(the last day prior to the public disclosure of Aurora's intention to pursue a combination with CanniMed), and )a 74.7% premium over the volume weighted average price ("VWAP") for CanniMed Shares for the last 20 trading days ended November 14, 2017.

MartialArts wrote:
Management at Aurora this part Monday January 15th to approved 170M shares for the acquisition of Cannimed. Here is the link: https://auroramj.com/special-meeting/notice-of-meeting.pdf

" approving the issuance of up to 170,000,000 Common Shares of the Corporation (the“Aurora Shares”) to the holders (the“CanniMed Common Shareholders”) ofcommon shares (the“CanniMed Shares”) of CanniMed Therapeutics Inc.(“CanniMed”), in connection with the offer (the“Offer”) made by the Corporation to the CanniMedCommon Shareholders to purchaseall of the CanniM edShares, all as more particularly described in theInformation Circular. "

So Aurora is ready to come to the table with more shares than it originally called for. On November 24th, Terry Booth, CEO of Aurora stated a clear ratio under the "Terms of the offer" "The offer will provide holders of CanniMed shares with 4.52586207 Aurora shares for each CanniMed share"

2017-11-24 07:41 CMED CanniMed Therapeutics Inc 20.65 News Release Aurora Cannabis launches hostile bid for CanniMed

Someone posted an important fact last night, there are only 24.43 M shares of CMED issued so under the November Aurora stated ratio, that means CMED 24.43M*4.52586207= 110.56M ACB needed for an all-share transaction for CMED.

So why the "up to 170M shares"? well that because they need to sweeten the deal to attract both management and the 66.6% of CMED holders to the table. Aurora is very intelligent, they know for acquisitions, they need to "step up" and have positioned themselves with the ability to do so.

It seems the Globe and Mail is already calling for the deal to be sweeten

2018-01-19 06:44 ACB Aurora Cannabis Inc 12.97 In the News Globe says Aurora to sweeten offer for CanniMed

Assuming they do the full 170M new ACB shares for the existing CMED 24.43M shares, that means CMED gets 6.96 ACB shares for each CMED shares.

And it might be the type of offer Aurora makes that is "too good to pass up". So although it's clear the CEO of Cannimed, Brent Zettl wants to stay on, he might be willing to just take the shares and step aside, or better yet, continue to head the Pharma division focussed on producing leading CanniMed Oils which already has tens of thousands of users as patients. Translate that to recreational and the olive oil based products could be a market hit on the recreational side.

And let's not forget that Aurora recently sold $200M worth of debentitures to raise cash for acquisitions. So this previous "all in share" transaction offer might morph into the very common shares plus cash typically seen in acquisitions. That allows investors on the CMED side to pull money out without depressing the share prices post-merger.

2018-01-05 08:03 ACB Aurora Cannabis Inc 13.04 News Release Aurora Cannabis to raise $200-million in bought deal

So Aurora is coming to the negociation table with cash and shares ready to deal with Cannimed. This is a very exciting time for the whole sector. If they complete the deal Aurora become #1 and overtakes Canopy Growth as the market cap leader.